Table 1.
Baseline characteristics of 4165 patients diagnosed with hepatocellular carcinoma (HCC) between 1981 and 2013 in our hospital
n (%) or mean ± SD | |
---|---|
Male/female | 2954 (70.9%)/1211 (29.1%) |
Age, mean ± SD (range) (years) | 66.2 ± 9.5 (17–95) |
Child–Pugh classification | |
Child–Pugh A/B/C | 2571 (65.4%)/1095 (27.9%)/265 (6.7%) |
Cause of liver disease | |
B/C/B and C/non-B, non-C | 460 (12.0%)/2734 (71.4%)/83 (2.2%)/551 (14.4%) |
Background liver | |
LC/CH/fatty liver/normal liver | 3073 (75.5%)/860 (21.1%)/11 (0.3%)/125 (3.1%) |
HCC stage | |
Stage I/II/III/IVA/IVB | 722 (18.1%)/1467 (36.8%)/1175 (29.5%)/501 (12.6%)/121 (3.0%) |
CH, chronic hepatitis; HCC, hepatocellular carcinoma; LC, liver cirrhosis; SD, standard deviation.